Russell Frank Company’s Assembly Biosciences ASMB Stock Holding History

Russell Frank Company’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-1	Closed	–	–	3444
2013 Q2	$0	Buy	+1	New	+$157	﹤0.01%	3348

Other funds holding ASMB

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Frank Company's ASMB Position: Q3 2013 in Review

Russell Frank Company sold out of Assembly Biosciences (ASMB) in Q3 2013, closing a stake of 1 share.

Russell Frank Company first reported a position in ASMB in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 37 funds tracked by Wall St. Rank hold ASMB as of Q3 2013.

Russell Frank Company reported no remaining Assembly Biosciences position as of Q3 2013 after selling out during the quarter.
Russell Frank Company sold 1 Assembly Biosciences share in Q3 2013.
Russell Frank Company first reported a position in Assembly Biosciences in Q2 2013 and held it in 1 quarter.
Russell Frank Company's Assembly Biosciences position peaked at $0 in Q2 2013.
37 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2013.

Based on Russell Frank Company's 13F filing for Q3 2013, filed 29 Oct 2013.